SHANGHAI, China – Tocopharm, a leading provider of high-quality pharmaceutical ingredients and specialized chemical solutions, successfully participated in the prestigious CPHI China 2026 exhibition held at the Shanghai New International Expo Centre (SNIEC). As one of the world's premier pharma events, CPHI Shanghai brings together global industry leaders, innovators, and suppliers to drive the future of pharmaceutical manufacturing and sourcing.

Tocopharm will join in API China 2026 from May 13 to May 15 at the National Exhibition and Convention Center (NECC) in Shanghai

Tocopharm joined in China International Agrochemical& Crop Protection Exhibition (CAC) 2026 from Mar.17 2026 to Mar. 19 2026

Tocopharm joined in ICIF China 2025 from Sep. 17 to Sep. 19 2025

Tocopharm will join in CPHI&PMEC Shenzhen China from Sep.01 to Sep.03 2025.

Tocopharm joined in CPHI&PMEC China 2025 Tocopharm Showcases Advanced Pharmaceutical Excipients at CPHI & PMEC China 2025 *June 24-26, 2025, Shanghai* – Tocopharm emerged as a key innovator at CPHI & PMEC China 2025 (Shanghai New International Expo Centre), Asia's largest pharmaceutical sourcing event. Among 3,500+ global exhibitors and 100,000+ professional visitors, Tocopharm presented cutting-edge excipient solutions accelerating drug development and sustainable manufacturing.